Press Releases

Press Releases

Patients For Affordable Drugs Delivers Petition to AbbVie Calling for End to Biosimilar Delay Deals

WASHINGTON, DC — Patients For Affordable Drugs sent a petition with more than 1,000 signatures demanding pharmaceutical giant AbbVie stop delaying the introduction of biosimilar alternatives to Humira, a move that hurts patients by keeping prices high. The company announced in April it had inked a deal with manufacturer Samsung Bioepis that would guarantee AbbVie market exclusivity on Humira — the […]

Press Releases

The Good, The Missing, and The Ugly: The Drug Price Proposals Announced by the Trump Administration

WASHINGTON, DC — President Trump today gave a highly-anticipated speech on his Administration’s plans to lower drug prices. He railed against high prices and a rigged system, and we appreciate that he brought the rhetorical heat. But we must judge this set of proposals based on the substance and the standard the president set himself […]

Press Releases

ALERT: PhRMA Spends Record $$$ Lobbying

WASHINGTON, DC — Patients For Affordable Drugs’ Executive Director, Ben Wakana, issued the following statement regarding the news that PhRMA, the pharmaceutical industry’s main trade organization, broke a record for money spent lobbying in the first quarter of 2018. “Drug corporations are running scared. The public knows the truth about America’s rigged prescription drug pricing system, so PhRMA is […]

Press Releases

Patient Group Calls For Investigation Into AbbVie’s abusive Pay-for-Delay deals

WASHINGTON, D.C. — Patients For Affordable Drugs (P4AD) called on the Federal Trade Commission to investigate a pay-for-delay deal cut by the pharmaceutical giant AbbVie. In a letter to Congress and the Federal Trade Commission, the patient group asked the FTC to investigate whether AbbVie’s recent deal with Samsung Bioepis is anti-competitive and violates antitrust laws. […]

Press Releases

Nationwide Patient Organization Endorses Ohio Bill to Lower Drug Prices

COLUMBUS, OHIO — Patients For Affordable Drugs (P4AD), a bipartisan national patient organization, endorsed HB 479, a bill to prohibit secretive contracts by drug corporation middlemen that keep Ohio patients in the dark about their prescription drug prices. Patients For Affordable Drugs brought together Ohio residents Saturday in Columbus for a training focused on how to effectively organize, […]

Press Releases

Higher Taxes on Drugs Won’t Lower Drug Prices

WASHINGTON, D.C. — Patients For Affordable Drugs Executive Director, Ben Wakana, issued the following statement regarding the Trump Administration’s plans to introduce tariffs on key drug ingredients. “For an administration that wants to lower drug prices, this would do the exact opposite. We are eager to read the comprehensive set of recommendations the administration promised to release in […]

Press Releases

Drug rebates for consumers — another Band-Aid on a systemic problem

WASHINGTON, D.C. — Patients For Affordable Drugs Executive Director, Ben Wakana, issued the following statement regarding the announcement that Aetna plans to pass drug rebates to consumers: “The recent changes announced by Aetna and United will offer some relief to about 10.5 million people — 3 percent of the U.S. population. These announcements are designed […]

Press Releases

Who Runs Washington? New Poll Shows Americans Think It's Drug Company Lobbyists

FOR IMMEDIATE RELEASE: March 23, 2018 A new Kaiser Family Foundation Health Tracking Poll found an overwhelming 72 percent of people think the drug industry has too much influence in Washington, outpolling Wall Street and the gun lobby. Ben Wakana, Executive Director of Patients For Affordable Drugs, released the following statement in response: “Drug company lobbyists pour […]